General Surgery CME Courses

General Surgery CME Courses

Format: Live Course
Price: Free
Release Date: 9/22/2015
Expiration Date: 3/22/2016
Summary: Some objectives for this course include the following:
  • Describe the range of immune response-related and dermatologic adverse events associated with existing and emerging immunomodulatory and targeted therapies for patients with metastatic melanoma.
  • Identify strategies for predicting response to therapy in patients with melanoma being treated with single agent or combination BRAF inhibition/immune modulators.
  • Select appropriate interventions to manage side effects in patients with melanoma being treated with single agent or combination immune-based/targeted therapy.

Share This